---
title: "Methdilazine - Angioedema"
sidebar: mydoc_sidebar
permalink: db00902-mesh-d000799-1.html
toc: false 
---


Path ID: `DB00902_MESH_D000799_1`
{% include image.html url="images/db00902-mesh-d000799-1.png" file="db00902-mesh-d000799-1.png" alt="db00902-mesh-d000799-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C044642 | methdilazine | Drug |
| UniProt:P35367 | Histamine H1 receptor | Protein |
| GO:0004969 | histamine receptor activity | MolecularActivity |
| GO:0002441 | histamine secretion involved in inflammatory response | BiologicalProcess |
| HP:0000282 | Facial edema | PhenotypicFeature |
| MESH:D000799 | Angioedema | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Methdilazine | DECREASES ACTIVITY OF | Histamine H1 Receptor |
| Histamine H1 Receptor | POSITIVELY REGULATES | Histamine Receptor Activity |
| Histamine Receptor Activity | PARTICIPATES IN | Histamine Secretion Involved In Inflammatory Response |
| Histamine Secretion Involved In Inflammatory Response | POSITIVELY CORRELATED WITH | Facial Edema |
| Facial Edema | MANIFESTATION OF | Angioedema |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00902](https://go.drugbank.com/drugs/DB00902)
